Search Results - Jonathan How
- Showing 1 - 1 results of 1
-
1
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor‐Naïve Patients With Myelofibrosis From the Multicenter, Open‐Label, Phase 2 Study (REFINE)... Autoría: Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad Mattour, Mary Frances McMullin, Andrew C. Perkins, Gabriela Rodriguez‐Macías, Hassan A. Sibai, Akshanth R. Polepally, Yan Sun, Avijeet S. Chopra, Jason G. Harb, Qin Qin, Jalaja Potluri, Jonathan How
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso